Navigating late-stage dementia: A perspective from the Alzheimer's Association
- PMID: 38496717
- PMCID: PMC10941565
- DOI: 10.1002/dad2.12530
Navigating late-stage dementia: A perspective from the Alzheimer's Association
Abstract
Alzheimer's disease (AD) is the most common cause of dementia, a general term for memory loss and decline in other cognitive abilities enough to interfere with daily life. AD accounts for 60% to 80% of dementia cases. The late stage of AD tends to be the shortest stage and, on average, lasts 1 to 2 years. As this stage of the condition progresses, it requires continuous intensive long-term care and around-the-clock intensive care. The Alzheimer's Association stands firm in its commitment to supporting individuals living with AD and other dementia, their care partners, and their health-care providers as they navigate treatment and care decisions across the continuum of the disease. This article is a direct response to recently published works that run counter to the Association's viewpoint. It outlines the Association's perspective on crucial factors for consideration during late-stage dementia care, including advanced directives, palliative care, nutrition, and legal considerations. It explores diverse perspectives from the field, differing from the Alzheimer's Association's stance. Last, it underscores resources available through the Alzheimer's Association, aiming to present a comprehensive perspective on late-stage care for support and assistance to all involved.
© 2024 The Authors. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring published by Wiley Periodicals LLC on behalf of Alzheimer's Association.
Conflict of interest statement
K. Clifford, M. Moreno, and C. M. Kloske are full‐time employee of the Alzheimer's Association. Author disclosures are available in the supporting information.
Similar articles
-
Alzheimer's Association's funding portfolio: Insights from the International Alzheimer's and Related Dementias Research Portfolio (IADRP).Alzheimers Dement. 2025 Jan;21(1):e14354. doi: 10.1002/alz.14354. Epub 2024 Dec 23. Alzheimers Dement. 2025. PMID: 39711499 Free PMC article.
-
Perspectives of patients, care partners, and primary care physicians on management of mild cognitive impairment and mild Alzheimer's disease dementia.Postgrad Med. 2023 Jun;135(5):530-538. doi: 10.1080/00325481.2023.2217025. Epub 2023 May 29. Postgrad Med. 2023. PMID: 37219410
-
Understanding the role of psychiatrists in the diagnosis and management of mild cognitive impairment and mild Alzheimer's disease dementia: a cross-sectional survey.BMC Psychiatry. 2023 Oct 4;23(1):716. doi: 10.1186/s12888-023-05129-5. BMC Psychiatry. 2023. PMID: 37794326 Free PMC article.
-
Souvenaid for Alzheimer's disease.Cochrane Database Syst Rev. 2020 Dec 15;12(12):CD011679. doi: 10.1002/14651858.CD011679.pub2. Cochrane Database Syst Rev. 2020. PMID: 33320335 Free PMC article.
-
NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease.Alzheimers Dement. 2018 Apr;14(4):535-562. doi: 10.1016/j.jalz.2018.02.018. Alzheimers Dement. 2018. PMID: 29653606 Free PMC article. Review.
Cited by
-
Synthesis of novel hybrids of 1,2,3-triazoles-hydrazone: targeting cholinesterases and Alzheimer's related genes.Future Med Chem. 2024 Aug 2;16(15):1519-1535. doi: 10.1080/17568919.2024.2359894. Epub 2024 Jun 12. Future Med Chem. 2024. PMID: 38864182 Free PMC article.
-
Advance Requests for Medical Assistance in Dying in the International Context: Some Legal Issues for the Canadian Case.Healthc Policy. 2025 Feb;20(2):17-24. doi: 10.12927/hcpol.2025.27478. Healthc Policy. 2025. PMID: 40276808
-
Identification of therapeutic targets for Alzheimer's Disease Treatment using bioinformatics and machine learning.Sci Rep. 2025 Jan 31;15(1):3888. doi: 10.1038/s41598-025-88134-w. Sci Rep. 2025. PMID: 39890844 Free PMC article.
-
Letter response to Clifford et al. "Navigating late-stage dementia: A perspective from the Alzheimer's Association".Alzheimers Dement (Amst). 2024 Oct 10;16(4):e70014. doi: 10.1002/dad2.70014. eCollection 2024 Oct-Dec. Alzheimers Dement (Amst). 2024. PMID: 39391024 Free PMC article. No abstract available.
References
-
- Alzheimer's Association . End‐of‐Life Decisions—Honoring the wishes of a person living with dementia 2022. https://www.alz.org/media/Documents/alzheimers-dementia-end-of-life-deci...
LinkOut - more resources
Full Text Sources
Research Materials